Study shows that aspirin treatment can be safely shortened after angioplasty in low-risk heart attack patients
Reducing aspirin to one month after a heart attack lowers bleeding risk without increasing cardiovascular complications.
Reducing aspirin to one month after a heart attack lowers bleeding risk without increasing cardiovascular complications.
A study led by the Clínic Barcelona Comprehensive Cancer Center —a center driven by Clínic-IDIBAPS and the University of Barcelona (UB)— demonstrat...
In recent weeks, several media outlets have raised questions about the safety of medicines such as semaglutide and tirzepatide. This article addres...
A systematic review published in eClinicalMedicine concludes that most antidepressants, when used appropriately, do not significantly increase the...
Hospital Clínic Barcelona appears once again in the two main rankings published by Newsweek alongside Statista. The hospital features in eleven spe...
Apheresis is a medical procedure by which specific components of a person’s blood are removed and the rest is returned to the bloodstream through o...
Researchers from Clínic-IDIBAPS, within the Clínic Barcelona Comprehensive Cancer Center, and the spin-off Gyala Therapeutics have coordinated a st...
Researchers from Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Center, have led a study analyzing how genetic m...
The digital project MigraAgile, promoted by the Hospital Clínic Barcelona in collaboration with the Primary Care Centres of the Barcelona Esquerra...
An international team led by the Clínic-IDIBAPS and the Institute of Cancer Research in London has developed an innovative new method based on DNA...